Local microcirculation improvement

Local microcirculation improvement refers to any intervention, mechanism, or physiological adaptation that enhances blood flow within the microvasculature—arterioles, capillaries, and venules—in a specific region or organ. This is achieved by modulating vascular tone (primarily via endothelial-derived substances such as nitric oxide or prostacyclin), recruiting inactive capillaries, and adapting perfusion to local metabolic demand. Clinically, improvement in microcirculation is sought in conditions where tissue perfusion is compromised, such as diabetes, sepsis, or ischemic tissue injury. Drugs or treatments may target the endothelium, vascular smooth muscle, or blood elements (e.g., red blood cells), but "local microcirculation improvement" is itself not a molecular entity—it is a therapeutic objective resulting from manipulation of multiple, defined targets and pathways. Interventions may include pharmacological agents (vasodilators, NO donors), physical methods (local vibration), or device-based therapies. In summary: "局部微循环改善（促进血液循环）" is not a defined molecule, receptor, or target, but a therapeutic effect achieved through manipulation of specific molecular pathways. For structured data mapping, this entry should be flagged as "is_incorrect: true" and not treated as a single molecular target. To obtain structured information, the underlying true targets should be identified, such as "Nitric oxide synthase," "Muscarinic acetylcholine receptor," "Prostacyclin receptor," etc., depending on the context.

Other names

Local blood circulation promotionmicrovascular perfusion enhancementmicrocirculatory blood flow improvement

Vasodilation via endothelial mediator release (e.g., NO, prostacyclin) Reduction of vascular resistance in microvessels Capillary recruitment Restoration of endothelial function